Biorithm raises $3.5M Series A for remote maternal monitoring tech
Biorithm announced that it closed a $3.5 million Series A funding round to support its personalized, connected maternity care technology.
Adaptive Capital Partners and SEEDS Capital co-led the funding round. Cambridge, Massachusetts-based Biorithm plans to use the funds to fuel its expansion in Southeast Asia and the U.S. It also plans to use the cash infusion to advance its Femom obstetric remote monitoring solution. That includes completing clinical studies to support an FDA 510(k) premarket submission.
